Researchers build a peptide that causes a receptor to form toxic, amyloid-like clumps in cells.

Using computational algorithms and experimental evolution, researchers are predicting antimicrobial-resistance patterns to improve drug design. 

See Scientist To Watch Phil Baran describe the artistry of his research in drug discovery.